Kazuhiro Tateoka
No ORCID on file
· 1 paper in corpus
· active 1996
Various hormone therapies for endometrial carcinoma have been reported in the literature using progestins, tamoxifen (anti-estrogen), danazol, Gn-RH etc. The response rates of these hormone therapies are reported to be approximately 30%, wh…